Interaction of polyacrylic acid coated and non-coated iron oxide nanoparticles with human neutrophils

Toxicology Letters

Volumn 225, Issue 1, 2014, Pages 57-65

  Couto, Diana ^a   Freitas, Marisa ^a   Vilas Boas, Vânia ^b   Dias, Irene ^a   Porto, Graça ^c   Lopez Quintela, M Arturo ^d   Rivas, José ^e   Freitas, Paulo ^e   Carvalho, Félix ^b   Fernandes, Eduarda ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Faculdade de Farmácia da Universidade do Porto   (Portugal)

^c HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY   (Portugal)

Author keywords

Apoptosis; Human neutrophils; Iron oxide nanoparticles; Nanotoxicology; Oxidative burst; Polyacrylic acid coating

Indexed keywords

IRON OXIDE; NANOPARTICLE; POLYACRYLIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY BURST;

APOPTOSIS; HUMAN NEUTROPHILS; IRON OXIDE NANOPARTICLES; NANOTOXICOLOGY; OXIDATIVE BURST; POLYACRYLIC ACID COATING;

ACRYLIC RESINS; APOPTOSIS; CASPASES; COATED MATERIALS, BIOCOMPATIBLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HUMANS; METAL NANOPARTICLES; NADPH OXIDASE; NECROSIS; NEUTROPHIL ACTIVATION; NEUTROPHILS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84890396434     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.11.020     Document Type: Article

References (52)

1. Apopa P.L., et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre Toxicol. 2009, 6:1.
2. Bae J.E., et al. The effect of static magnetic fields on the aggregation and cytotoxicity of magnetic nanoparticles. Biomaterials 2011, 32(35):9401-9414.
3. Bockmann S., et al. Delay of neutrophil apoptosis by the neuropeptide substance P: involvement of caspase cascade. Peptides 2001, 22(4):661-670.
4. Brasen J.C., et al. On the mechanism of oscillations in neutrophils. Biophys. Chem. 2010, 148(1-3):82-92.
5. 4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells. Int. J. Nanomed. 2009, 4:65-71.
6. Chen F., Shi X. Intracellular signal transduction of cells in response to carcinogenic metals. Crit. Rev. Oncol. Hematol. 2002, 42(1):105-121.
7. Choi S.J., et al. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J. Inorg. Biochem. 2009, 103(3):463-471.
8. Circu M.L., Aw T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Biol. Med. 2010, 48(6):749-762.
9. Dilnawaz F., et al. Transferrin-conjugated curcumin-loaded superparamagnetic iron oxide nanoparticles induce augmented cellular uptake and apoptosis in K562 cells. Acta Biomater. 2012, 8(2):704-719.
10. Fadeel B., et al. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998, 92(12):4808-4818.
11. Franco R., et al. Environmental toxicity, oxidative stress and apoptosis: menage a trois. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2009, 674(1-2):3-22.
12. Freitas M., et al. Nickel induces apoptosis in human neutrophils. Biometals 2013, 26(1):13-21.
13. Freitas M., et al. Acetaminophen prevents oxidative burst and delays apoptosis in human neutrophils. Toxicol. Lett. 2013, 219(2):170-177.
14. Freitas M., et al. Nickel induces oxidative burst, NF-kappaB activation and interleukin-8 production in human neutrophils. J. Biol. Inorg. Chem. 2010, 15(8):1275-1283.
15. Freitas M., et al. Optical probes for detection and quantification of neutrophils' oxidative burst: a review. Anal. Chim. Acta 2009, 649(1):8-23.
16. Freitas M., et al. Isolation and activation of human neutrophils in vitro. The importance of the anticoagulant used during blood collection. Clin. Biochem. 2008, 41(7-8):570-575.
17. Freitas M., et al. Optimization of experimental settings for the analysis of human neutrophils oxidative burst in vitro. Talanta 2009, 78(4-5):1476-1483.
18. 2) nanoparticles. Toxicol. In Vitro 2010, 24(3):1002-1008.
19. Hong S.C., et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int. J. Nanomed. 2011, 6:3219-3231.
20. Huang D.M., et al. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 2009, 30(22):3645-3651.
21. Huang J., et al. Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J. Pharmacol. Sci. 2008, 107(4):370-379.
22. Hussain S.M., et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19(7):975-983.
23. Karlsson H.L., et al. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21(9):1726-1732.
24. 4) nanocrystals affect the expression of genes involved in the TGF-beta signalling pathway. Mol .Biosyst. 2011, 7(5):1481-1486.
25. Kroemer G., et al. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87(1):99-163.
26. Letuve S., et al. Critical role of mitochondria, but not caspases, during glucocorticosteroid-induced human eosinophil apoptosis. Am. J. Respir. Cell Mol. Biol. 2002, 26(5):565-571.
27. Lunov O., et al. The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials 2010, 31(19):5063-5071.
28. Lunov O., et al. Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials 2010, 31(34):9015-9022.
29. Massart R., et al. Preparation and properties of monodisperse magnetic fluids. J. Magn. Magn. Mater. 1995, 149(1-2):1-5.
30. Matsushita T., et al. Inflammatory imaging with ultrasmall superparamagnetic iron oxide. Magn. Reson. Imaging 2011, 29(2):173-178.
31. Miyake N., et al. Rapamycin induces p53-independent apoptosis through the mitochondrial pathway in non-small cell lung cancer cells. Oncol. Rep. 2012, 28(3):848-854.
32. Mou Y., et al. Influence of synthetic superparamagnetic iron oxide on dendritic cells. Int. J. Nanomed. 2011, 6:1779-1786.
33. Muller K., et al. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials 2007, 28(9):1629-1642.
34. Naqvi S., et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int. J. Nanomed. 2010, 5:983-989.
35. Pineiro-Redondo Y., et al. The influence of colloidal parameters on the specific power absorption of PAA-coated magnetite nanoparticles. Nanoscale Res. Lett. 2011, 6(1):383.
36. Roohi F., et al. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles. Int. J. Nanomed. 2012, 7:4447-4458.
37. Rowe S.J., et al. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J. Immunol. 2002, 169(11):6401-6407.
38. Sakaguchi K., et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998, 12(18):2831-2841.
39. Saldanha-Gama R.F., et al. Alpha(9)beta(1) integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members. Biochim. Biophys. Acta, Mol. Cell Res. 2010, 1803(7):848-857.
40. Sharma V., et al. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012, 17(8):852-870.
41. Shubayev V.I., et al. Magnetic nanoparticles for theragnostics. Adv. Drug Deliv. Rev. 2009, 61(6):467-477.
42. Simbula G., et al. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis 2007, 12(1):113-123.
43. Sladek Z., et al. Neutrophil apoptosis during experimentally induced Staphylococcus aureus mastitis. Vet. Res. 2005, 36(4):629-643.
44. Thompson T., et al. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis. J. Biol. Chem. 2004, 279(51):53015-53022.
45. Turina M., et al. Endotoxin inhibits apoptosis but induces primary necrosis in neutrophils. Inflammation 2005, 29(1):55-63.
46. Wang L., et al. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn. Reson. Imaging 2009, 27(1):108-119.
47. Watson R.W., et al. The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J. Immunol. 1998, 161(2):957-962.
48. Weinmann P., et al. Bcl-Xl- and Bax-alpha-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood 1999, 93(9):3106-3115.
49. Wu J., et al. Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicology 2012, 34:243-253.
50. Wu J., Sun J. Investigation on mechanism of growth arrest induced by iron oxide nanoparticles in PC12 cells. J. Nanosci. Nanotechnol. 2011, 11(12):11079-11083.
51. 4 nanoparticles with daunorubicin induce apoptosis through caspase 8-PARP pathway and inhibit K562 leukemia cell-induced tumor growth in vivo. Nanomedicine 2011, 7(5):595-603.
52. Zhu M.T., et al. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol. Lett. 2011, 203(2):162-171.